Recalls, Availability, and Content of Dietary Supplements Following FDA Warning Letters. Cohen PA, Avula B, Katragunta K, Khan I, et al. JAMA 2022;328:393-395.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cohen PA, Avula B, Katragunta K, Khan I, et al. Recalls, Availability, and Content of Dietary Supplements Following FDA Warning Letters. JAMA 2022;328:393-395.
PMID: 35881132